TLN-232, also known as CAP-232, is a synthetic cyclic heptapeptide with potential antineoplastic activity. Pyruvate kinase (PK) inhibitor TLN-232 targets pyruvate kinase M2 (M2PK), which may disrupt tumor cell anaerobic glycolysis. M2PK is a dimeric isoform of PK and the predominant PK isoform found in tumor cells.
Molecular Weight:
783.96
CAS Number:
[158899-10-6]
Formula:
C36H49N9O7S2
Target:
Others
T70418
* VAT and and shipping costs not included. Errors and price changes excepted